Source:http://linkedlifedata.com/resource/pubmed/id/18702503
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
36
|
pubmed:dateCreated |
2008-9-4
|
pubmed:abstractText |
All three classes of serine beta-lactamases are inhibited at micromolar levels by 1:1 complexes of catechols with vanadate. Vanadate reacts with catechols at submillimolar concentrations in aqueous buffer at neutral pH in several steps, initially forming 1:1, 1:2, and, possibly, 1:3 complexes. Formation of these complexes is followed by the slower reduction of vanadate (V (V)) to vanadyl (V (IV)) and oxidation of the catechol. Vanadyl-catechol complexes, however, do not inhibit the beta-lactamases. Rate and equilibrium constants of formation of the 1:1 and 1:2 complexes of vanadate with catechol itself and with 2,3-dihydroxynaphthalene were measured by stopped-flow spectrophotometry. Typical examples of all three classes of serine beta-lactamases (the class A TEM-2, class C P99, and class D OXA-1 enzymes) were competitively inhibited by the 1:1 vanadate-catechol complexes. The inhibition was modestly enhanced by hydrophobic substituents on the catechol. The 1:1 vanadate complexes are considerably better inhibitors of the P99 beta-lactamase than 1:1 complexes of catechol with boric acid and are likely to contain penta- or hexacoordinated vanadium rather than tetracooordinated. Molecular modeling showed that a pentacoordinated 1:1 vanadate-catechol complex readily fits into the class C beta-lactamase active site with coordination to the nucleophilic serine hydroxyl oxygen. Such complexes may resemble the pentacoordinated transition states of phosphyl transfer, a reaction also catalyzed by beta-lactamases.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Catechols,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Vanadates,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1520-4995
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9467-74
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18702503-Bacterial Proteins,
pubmed-meshheading:18702503-Catechols,
pubmed-meshheading:18702503-Enterobacter cloacae,
pubmed-meshheading:18702503-Enzyme Inhibitors,
pubmed-meshheading:18702503-Hydrophobic and Hydrophilic Interactions,
pubmed-meshheading:18702503-Models, Molecular,
pubmed-meshheading:18702503-Oxidation-Reduction,
pubmed-meshheading:18702503-Vanadates,
pubmed-meshheading:18702503-beta-Lactamases
|
pubmed:year |
2008
|
pubmed:articleTitle |
Inhibition of serine beta-lactamases by vanadate-catechol complexes.
|
pubmed:affiliation |
Department of Chemistry, Wesleyan University, Middletown, Connecticut 06459, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|